Shanghai - Delayed Quote CNY
Shanghai Rendu Biotechnology Co., Ltd. (688193.SS)
38.00
+1.00
+(2.70%)
At close: 3:00:04 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Minghui Yu | GM & Director | -- | -- | 1983 |
| Mr. Tingjiang Cai | Accounting Supervisor, CFO & Secretary | -- | -- | 1974 |
| Ms. Ruohua Cao | Deputy GM & Director | -- | -- | 1966 |
| Ms. Zhenling Cui | Senior Director of R&D | -- | -- | 1978 |
| Mr. Feng man Zhou | Deputy Director of Instrumentation | -- | -- | 1990 |
Shanghai Rendu Biotechnology Co., Ltd.
Zhangjiang High Tech Park
Block A, building 15 NO.528 Ruiqing Road East District
Shanghai, 201201
China
- Sector:
- Healthcare
- Industry: Diagnostics & Research
Description
Shanghai Rendu Biotechnology Co., Ltd. engages in the development and promotion of RNA molecular diagnostic technology and products. The company offers products in the areas of reproductive health, respiratory diseases, enterovirus, food safety, and blood infectious diseases, as well as automatic nucleic acid detection and analysis system. The company was founded in 2007 and is based in Shanghai, China.
Corporate Governance
Shanghai Rendu Biotechnology Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
October 30, 2024 at 12:00 AM UTC
Ex-Dividend Date